Cannabis Science’s University Scholarship Expo Begins This Weekend; Register Now at the Company’s Flagship Location: CBIS Cali Rx, 14006 Ventura Boulevard, Sherman Oaks, CA
This Post Was Syndicated Under License Via QuoteMedia IRVINE, CA, June 08, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce ... [Read]
Phase I Underway, Cannabis Science 1,000-Acre Elpasso Farms Economic Development Plan in South Africa; Agriculture, Food Security, Phytomedicines, with an Emphasis on Micro-Nutrients, and Education
This Post Was Syndicated Under License Via QuoteMedia Pan African Ambassador for Food Security, Dr. Brylyne Chitsunge, Owner of Elpasso Farms Joins Cannabis Science Scientific Advisory Board IRVINE, CA, June 05, 2018 (GLOBE NEWSWIRE) -- ... [Read]
Chemistree Enters Into Definitive Agreements for Washington State Asset Acquisition
This Post Was Syndicated Under License Via QuoteMedia Company to Complete Change of Business Filing VANCOUVER, British Columbia, June 01, 2018 (GLOBE NEWSWIRE) -- Chemistree Technology Inc. (CSE:CHM) (OTCQB:CHMJF) (the “Company” or “Chemistree”) further to ... [Read]
Cannabis Science CEO Receives Prestigious Industry Leader Award at 2018 Global Health Catalyst Summit at Harvard Medical School and Announces Major Collaboration With Elpasso Farms in South Africa
This Post Was Syndicated Under License Via QuoteMedia BOSTON, MA, May 29, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces that the Company ... [Read]
2018 Global Health Catalyst Summit at Harvard Medical School is Streaming Live Now; Watch CBIS Executives Present Live
This Post Was Syndicated Under License Via QuoteMedia IRVINE, CA, May 25, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces the Company’s participation ... [Read]
Cannabis Science President & CEO Mr. Raymond C. Dabney Awarded The 2018 Harvard Global Health Catalyst Industry Leader Award May 25-27th at Harvard Medical School, Boston, MA
This Post Was Syndicated Under License Via QuoteMedia IRVINE, CA, May 14, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces that Mr. Raymond ... [Read]
Chemistree Announces LOI for Washington State Asset Acquisition, and up to $2.1 Million Non-Brokered Private Placement Financing
This Post Was Syndicated Under License Via QuoteMedia Company to Complete Change of Business Filing This press release is not to be distributed to U.S. newswire services or to be disseminated in the United States. ... [Read]
Cannabis Science Announces the Second Frontiers Peer-Reviewed Publication of its Research Results on the Use of Cannabinoids in the Treatment of Cancers
This Post Was Syndicated Under License Via QuoteMedia IRVINE, CA, May 01, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces the second publication ... [Read]
Inspired by the Upcoming CNN Special Report, Weed: Pot Vs. Pills, by Dr. Sanjay Gupta, Cannabis Science Announces its ‘Cannabis Science to End Opioid Deaths Campaign’
This Post Was Syndicated Under License Via QuoteMedia IRVINE, CA, April 27, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, and its partner, Cali ... [Read]
Cannabis Science is Proud to Announce 4/20 Success! Opening of the First CBIS Cali Rx Location on Ventura Blvd, in Sherman Oaks, California
This Post Was Syndicated Under License Via QuoteMedia IRVINE, CA, April 23, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC:CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, and its partner, Cali RX, ... [Read]